Obálka

Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients

Podrobná bibliografia
Hlavní autori:	Kiss, I. (Autor), Halamkova, J. (Autor), Jarkovsky, J. (Autor), Tomasek, J. (Autor), Zavrelova, J. (Autor), Hanakova, L. (Autor), Man, M. (Autor), Moulis, M. (Autor), Penka, M. (Autor), Robek, O. (Autor), Benda, P. (Autor), Tucek, S. (Autor), Cech, Z. (Autor), Kala, Zdeněk, 1960- (Autor), Pavlovsky, Z. (Autor)
Médium:	Článok
Jazyk:	angličtina

Podobné exempláre

Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patients
Autor: Bednarova, D., a ďalší

D-dimer, plasminogen activator inhibitor-1, prothrombin fragments and protein С - role in prothrombotic state of colorectal cancer
Autor: Stasko, J., a ďalší

Colorectal carcinoma and cholecystectomy
Autor: Hladík, V., a ďalší

Plasminogen activator inhibitor type 2: potential prognostic factor for endometrial carcinomas
Autor: Osmak, M., a ďalší

NEW PROGNOSTIC MARKERS IN BREAST CANCER - UROKINASE PLASMINOGEN ACTIVATOR AND PLASMINOGEN INHIBITOR TYPE 1 - OUR EXPERIENCE
Autor: Rácová, K., a ďalší